Spots Global Cancer Trial Database for Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

Official Title: A Surgical Window Pilot Investigation of Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

Study ID: NCT03771651

Conditions

Fallopian Tube Cancer

Fallopian Tube Infection

Interventions

Aspirin 81 mg

Study Description

Brief Summary: This study will evaluate the impact of low dose aspirin on normal fallopian tube fimbriae in women who have surgery to have their fallopian tubes removed. Participants will take a low dose of aspirin for 2 weeks before their surgery. A portion of the removed fallopian tubes will also be collected for future research and routine pathology purposes.

Detailed Description: Subjects in this study will receive low dose aspirin for 14 days before undergoing surgery to remove fallopian tubes removed to determine whether aspirin decreases inflammation in the fallopian tube. Subjects will also submit blood samples at their initial visit with their oncologist, at the time of surgery and at the pre-operative visit to measure inflammation markers and blood counts. A portion of the subject's fallopian tube will be collected for future research studies.